期刊
MINI-REVIEWS IN MEDICINAL CHEMISTRY
卷 18, 期 10, 页码 828-836出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557517666170927141323
关键词
Aripiprazole; carteolol; cilostazol; 3,4-dihydro-2(1H)-quinolinone; pharmacology; drug design
资金
- National Research Foundation of South Africa [85642, 96180]
- NRF
The 3,4-dihydro-2(1H)-quinolinone moiety is present in a number of pharmacologically active compounds. These include FDA approved drugs such as cilostazol, carteolol and aripiprazole as well as numerous experimental compounds. Compounds containing the 3,4-dihydro-2(1H)-quinolinone moiety also exhibit a variety of activities in both the peripheral and central tissues, which includes phosphodiesterase inhibition, blocking of beta-adrenergic receptors, antagonism of vasopressin receptors and interaction with serotonin and dopamine receptors. Based on its versatility in drug design and action, this paper reviews the pharmacological actions of compounds containing the 3,4-dihydro-2(1H)quinolinone scaffold with emphasis being placed on the most important and significant members of each activity class.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据